ReviewMicrobiologyOpen2026
From Oral Candidiasis to Candidemia: A Review of Superficial to Invasive Progression.
Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Oral candidiasis is the most prevalent fungal infection of the oral cavity and is frequently associated with immunosuppression. Although traditionally classified as a superficial condition, growing evidence suggests that oral infection with Candida sp. in a susceptible host may disseminate and evolve into invasive candidiasis, such as bloodstream infection (candidemia), one of the leading nosocomial infections associated with high mortality. This review addresses the clinical manifestations of oral candidiasis, local and systemic risk factors, and the emerging role of non-albicans Candida and related yeasts in the pathogenesis of both candidiasis and candidemia. Furthermore, we revisit antifungal resistance, the interaction between Candida albicans and the oral microbiome, and the potential impact of these interactions on progression to invasive infection. Animal models of oral candidiasis and candidemia are also considered, highlighting their relevance for understanding virulence mechanisms and for developing new therapeutic strategies. In an integrative way, this review summarizes current evidence on the relationship between oral candidiasis and candidemia, emphasizing the importance of early diagnosis, prevention, and the search for alternative therapies in light of antifungal resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.